Initial concerns regarding drug-induced ILD in RA patients arose after anecdotal reports of serious exacerbations of respiratory disease following treatment with a TNF inhibitor (TNFi) in patients with pre-existing RA-ILD. Here, TNF is linked to interstitial lung disease.